Reduced radiation after surgery for advanced head and neck cancer
Part of Cancer clinical trials.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head and neck squamous cell carcinoma in the mouth, throat, voice box, or nearby areas, with specific advanced stage (III to IVB).
- You already had neoadjuvant treatment and radical surgery, completed within the last 6 weeks; then you are being considered for postoperative radiation.
- Your pathology report from surgery must show either pCR (no viable tumor cells) or MPR (≤10% residual viable tumor cells).
- Your surgery must have a negative margin, and there must be no extranodal extension (no cancer spread beyond the lymph node capsule).
- You are age 18 to 70, and your general activity level is ECOG 0–2 (able to do self-care, with limited symptoms).
- You must be able to take treatment safely (blood counts, liver/kidney tests, and clotting) and have no major exclusions like pregnancy, severe infections, or significant uncontrolled heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether giving low-dose radiation before surgery—along with chemotherapy and an immunotherapy drug—can work better and be safe for treating locally advanced head and neck squamous cell cancer. It may help shrink tumors before surgery and reduce the chance of the cancer coming back.
This trial tests a shorter course of radiation for people with intermediate-risk head and neck cancer after surgery. It aims to reduce side effects while keeping treatment effective.
This study tests whether surgery can reduce the amount of radiation needed for HPV-related neck cancer that started from an unknown spot. If eligible, you may get a less intense radiation plan after a targeted surgery.
This trial looks at whether patients with head and neck squamous cell carcinoma who had a good response to chemotherapy and immunotherapy before surgery can safely have less radiation after surgery. It aims to reduce side effects while keeping treatment effective.
This trial compares a less extensive surgery to the standard surgery for patients with advanced head and neck cancer who have responded well to initial chemotherapy and immunotherapy. The goal is to see if a smaller operation can be just as effective while causing fewer side effects.
This trial is testing whether giving less radiation after surgery is safe and effective for people with oral cancer whose surgery results were very good (no cancer cells or very few left). It aims to reduce side effects while still preventing cancer from coming back.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.